Main Chamber and Preburner Injector Technology

This document reports the experimental and analytical research carried out at the Penn State Propulsion Engineering Research Center in support of NASA's plan to develop advanced technologies for future single stage to orbit (SSTO) propulsion systems. The focus of the work is on understanding specific technical issues related to bi-propellant and tri-propellant thrusters. The experiments concentrate on both cold flow demonstrations and hot-fire uni-element tests to demonstrate concepts that can be incorporated into hardware design and development. The analysis is CFD-based and is intended to support the design and interpretation of the experiments and to extrapolate findings to full-scale designs. The research is divided into five main categories that impact various SSTO development scenarios. The first category focuses on RP-1/gaseous hydrogen (GH2)/gaseous oxygen (GO2) tri-propellant combustion with specific emphasis on understanding the benefits of hydrogen addition to RP-1/oxygen combustion and in developing innovative injector technology. The second category investigates liquid oxygen (LOX)/GH2 combustion at main chamber near stoichiometric conditions to improve understanding of existing LOX/GH2 rocket systems. The third and fourth categories investigate the technical issues related with oxidizer-rich and fuel-rich propulsive concepts, issues that are necessary for developing the full-flow engine cycle. Here, injector technology issues for both LOX/GH2 and LOX/RP-1 propellants are examined. The last category, also related to the full-flow engine cycle, examines injector technology needs for GO2/GH2 propellant combustion at near-stoichiometric conditions for main chamber application

Extravehicular activities limitations study. Volume 1: Physiological limitations to extravehicular activity in space

This report contains the results of a comprehensive literature search on physiological aspects of EVA. Specifically, the topics covered are: (1) Oxygen levels; (2) Optimum EVA work; (3) Food and Water; (4) Carbon dioxide levels; (5) Repetitive decompressions; (6) Thermal, and (7) Urine collection. The literature was assessed on each of these topics, followed by statements on conclusions and recommended future research needs

Cadmium, Lead, and Mercury in Relation to Reproductive Hormones and Anovulation in Premenopausal Women

Background: Metals can interfere with hormonal functioning by binding at the receptor site and through indirect mechanisms; thus, they may be associated with hormonal changes in premenopausal women

Abnormal expression of p27kip1 protein in levator ani muscle of aging women with pelvic floor disorders – a relationship to the cellular differentiation and degeneration

BACKGROUND: Pelvic floor disorders affect almost 50% of aging women. An important role in the pelvic floor support belongs to the levator ani muscle. The p27/kip1 (p27) protein, multifunctional cyclin-dependent kinase inhibitor, shows changing expression in differentiating skeletal muscle cells during development, and relatively high levels of p27 RNA were detected in the normal human skeletal muscles. METHODS: Biopsy samples of levator ani muscle were obtained from 22 symptomatic patients with stress urinary incontinence, pelvic organ prolapse, and overlaps (age range 38–74), and nine asymptomatic women (age 31–49). Cryostat sections were investigated for p27 protein expression and type I (slow twitch) and type II (fast twitch) fibers. RESULTS: All fibers exhibited strong plasma membrane (and nuclear) p27 protein expression. cytoplasmic p27 expression was virtually absent in asymptomatic women. In perimenopausal symptomatic patients (ages 38–55), muscle fibers showed hypertrophy and moderate cytoplasmic p27 staining accompanied by diminution of type II fibers. Older symptomatic patients (ages 57–74) showed cytoplasmic p27 overexpression accompanied by shrinking, cytoplasmic vacuolization and fragmentation of muscle cells. The plasma membrane and cytoplasmic p27 expression was not unique to the muscle cells. Under certain circumstances, it was also detected in other cell types (epithelium of ectocervix and luteal cells). CONCLUSIONS: This is the first report on the unusual (plasma membrane and cytoplasmic) expression of p27 protein in normal and abnormal human striated muscle cells in vivo. Our data indicate that pelvic floor disorders are in perimenopausal patients associated with an appearance of moderate cytoplasmic p27 expression, accompanying hypertrophy and transition of type II into type I fibers. The patients in advanced postmenopause show shrinking and fragmentation of muscle fibers associated with strong cytoplasmic p27 expression

Transformative Materials to Create 3D Functional Human Tissue Models In Vitro in a Reproducible Manner

Recreating human tissues and organs in the petri dish to establish models as tools in biomedical sciences has gained momentum. These models can provide insight into mechanisms of human physiology, disease onset, and progression, and improve drug target validation, as well as the development of new medical therapeutics. Transformative materials play an important role in this evolution, as they can be programmed to direct cell behavior and fate by controlling the activity of bioactive molecules and material properties. Using nature as an inspiration, scientists are creating materials that incorporate specific biological processes observed during human organogenesis and tissue regeneration. This article presents the reader with state-of-the-art developments in the field of in vitro tissue engineering and the challenges related to the design, production, and translation of these transformative materials. Advances regarding (stem) cell sources, expansion, and differentiation, and how novel responsive materials, automated and large-scale fabrication processes, culture conditions, in situ monitoring systems, and computer simulations are required to create functional human tissue models that are relevant and efficient for drug discovery, are described. This paper illustrates how these different technologies need to converge to generate in vitro life-like human tissue models that provide a platform to answer health-based scientific questions.</p

A Genome-Wide Analysis of FRT-Like Sequences in the Human Genome

Efficient and precise genome manipulations can be achieved by the Flp/FRT system of site-specific DNA recombination. Applications of this system are limited, however, to cases when target sites for Flp recombinase, FRT sites, are pre-introduced into a genome locale of interest. To expand use of the Flp/FRT system in genome engineering, variants of Flp recombinase can be evolved to recognize pre-existing genomic sequences that resemble FRT and thus can serve as recombination sites. To understand the distribution and sequence properties of genomic FRT-like sites, we performed a genome-wide analysis of FRT-like sites in the human genome using the experimentally-derived parameters. Out of 642,151 identified FRT-like sequences, 581,157 sequences were unique and 12,452 sequences had at least one exact duplicate. Duplicated FRT-like sequences are located mostly within LINE1, but also within LTRs of endogenous retroviruses, Alu repeats and other repetitive DNA sequences. The unique FRT-like sequences were classified based on the number of matches to FRT within the first four proximal bases pairs of the Flp binding elements of FRT and the nature of mismatched base pairs in the same region. The data obtained will be useful for the emerging field of genome engineering

Velocity-selected production of 2S3 metastable positronium

Positronium in the 2 3 S metastable state exhibits a low electrical polarizability and a long lifetime (1140 ns), making it a promising candidate for interferometry experiments with a neutral matter-antimatter system. In the present work, 2 3 S positronium is produced, in the absence of an electric field, via spontaneous radiative decay from the 3 3 P level populated with a 205-nm UV laser pulse. Thanks to the short temporal length of the pulse, 1.5 ns full width at half maximum, different velocity populations of a positronium cloud emitted from a nanochanneled positron-positronium converter were selected by delaying the excitation pulse with respect to the production instant. 2 3 S positronium atoms with velocity tuned between 7 7 10 4 ms 121 and 10 7 10 4 ms 121 were thus produced. Depending on the selected velocity, a 2 3 S production efficiency ranging from 3c0.8% to 3c1.7%, with respect to the total amount of emitted positronium, was obtained. The observed results give a branching ratio for the 3 3 P-2 3 S spontaneous decay of (9.7 \ub1 2.7)%. The present velocity selection technique could allow one to produce an almost monochromatic beam of 3c1 7 10 3 2 3 S atoms with a velocity spread of &lt;10 4 ms 121 and an angular divergence of 3c50 mrad

Gravity and antimatter: The AEgIS experiment at CERN

open62siFrom the experimental point of view, very little is known about the gravitational interaction between matter and antimatter. In particular, the Weak Equivalence Principle, which is of paramount importance for the General Relativity, has not yet been directly probed with antimatter. The main goal of the AEgIS experiment at CERN is to perform a direct measurement of the gravitational force on antimatter. The idea is to measure the vertical displacement of a beam of cold antihydrogen atoms, traveling in the gravitational field of the Earth, by the means of a moiré deflectometer. An overview of the physics goals of the experiment, of its apparatus and of the first results is presented.openPagano D.; Aghion S.; Amsler C.; Bonomi G.; Brusa R.S.; Caccia M.; Caravita R.; Castelli F.; Cerchiari G.; Comparat D.; Consolati G.; Demetrio A.; Noto L.D.; Doser M.; Evans A.; Fani M.; Ferragut R.; Fesel J.; Fontana A.; Gerber S.; Giammarchi M.; Gligorova A.; Guatieri F.; Haider S.; Hinterberger A.; Holmestad H.; Kellerbauer A.; Khalidova O.; Krasnicky D.; Lagomarsino V.; Lansonneur P.; Lebrun P.; Malbrunot C.; Mariazzi S.; Marton J.; Matveev V.; Mazzotta Z.; Muller S.R.; Nebbia G.; Nedelec P.; Oberthaler M.; Pacifico N.; Penasa L.; Petracek V.; Prelz F.; Prevedelli M.; Ravelli L.; Rienaecker B.; Robert J.; Rohne O.M.; Rotondi A.; Sandaker H.; Santoro R.; Smestad L.; Sorrentino F.; Testera G.; Tietje I.C.; Widmann E.; Yzombard P.; Zimmer C.; Zmeskal J.; Zurlo N.Pagano, D.; Aghion, S.; Amsler, C.; Bonomi, G.; Brusa, R. S.; Caccia, M.; Caravita, R.; Castelli, F.; Cerchiari, G.; Comparat, D.; Consolati, G.; Demetrio, A.; Noto, L. D.; Doser, M.; Evans, A.; Fani, M.; Ferragut, R.; Fesel, J.; Fontana, A.; Gerber, S.; Giammarchi, M.; Gligorova, A.; Guatieri, F.; Haider, S.; Hinterberger, A.; Holmestad, H.; Kellerbauer, A.; Khalidova, O.; Krasnicky, D.; Lagomarsino, V.; Lansonneur, P.; Lebrun, P.; Malbrunot, C.; Mariazzi, S.; Marton, J.; Matveev, V.; Mazzotta, Z.; Muller, S. R.; Nebbia, G.; Nedelec, P.; Oberthaler, M.; Pacifico, N.; Penasa, L.; Petracek, V.; Prelz, F.; Prevedelli, M.; Ravelli, L.; Rienaecker, B.; Robert, J.; Rohne, O. M.; Rotondi, A.; Sandaker, H.; Santoro, R.; Smestad, L.; Sorrentino, F.; Testera, G.; Tietje, I. C.; Widmann, E.; Yzombard, P.; Zimmer, C.; Zmeskal, J.; Zurlo, N

AEg̅IS latest results

The validity of the Weak Equivalence Principle (WEP) as predicted by General Relativity has been tested up to astounding precision using ordinary matter. The lack hitherto of a stable source of a probe being at the same time electrically neutral, cold and stable enough to be measured has prevented highaccuracy testing of the WEP on anti-matter. The AEg̅IS (Antimatter Experiment: Gravity, Interferometry, Spectroscopy) experiment located at CERN's AD (Antiproton Decelerator) facility aims at producing such a probe in the form of a pulsed beam of cold anti-hydrogen, and at measuring by means of a moiré deflectometer the gravitational force that Earth's mass exerts on it. Low temperature and abundance of the H̅ are paramount to attain a high precision measurement. A technique employing a charge-exchange reaction between antiprotons coming from the AD and excited positronium atoms is being developed at AEg̅IS and will be presented hereafter, alongside an overview of the experimental apparatus and the current status of the experimen

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.

Tenofovir disoproxil fumarate (TDF) genotypic resistance defined by K65R/N and/or K70E/Q/G occurs in 20% to 60% of individuals with virological failure (VF) on a WHO-recommended TDF-containing first-line regimen. However, the full spectrum of reverse transcriptase (RT) mutations selected in individuals with VF on such a regimen is not known. To identify TDF regimen-associated mutations (TRAMs), we compared the proportion of each RT mutation in 2873 individuals with VF on a WHO-recommended first-line TDF-containing regimen to its proportion in a cohort of 50,803 antiretroviral-naïve individuals. To identify TRAMs specifically associated with TDF-selection pressure, we compared the proportion of each TRAM to its proportion in a cohort of 5805 individuals with VF on a first-line thymidine analog-containing regimen. We identified 83 TRAMs including 33 NRTI-associated, 40 NNRTI-associated, and 10 uncommon mutations of uncertain provenance. Of the 33 NRTI-associated TRAMs, 12 - A62V, K65R/N, S68G/N/D, K70E/Q/T, L74I, V75L, and Y115F - were more common among individuals receiving a first-line TDF-containing compared to a first-line thymidine analog-containing regimen. These 12 TDF-selected TRAMs will be important for monitoring TDF-associated transmitted drug-resistance and for determining the extent of reduced TDF susceptibility in individuals with VF on a TDF-containing regimen